Topical, Aqueous, Clear Cyclosporine Formulation Design for Anterior and Posterior Ocular Delivery
Cited by (105)
Items 101–105 of 105
- Topical cyclosporine A formulations in ophthalmology: a literature reviewSergey V. Trufanov, Inna A. Riks · 2026 · The EYE GLAZ
- Effects of Treatment With Cyclosporine Ophthalmic Solution 0.09% on Dry Eye Questionnaire Scores Among Patients With Dry Eye DiseaseRana Taji, King Y. Chow, Shazia Hassan, Belinda Yap · 2026 · Cureus
- Dapagliflozin embedded polymeric nanomicelles for enhanced ocular drug delivery: A promising strategy for glaucoma therapyAarya Chitre, Vividha S. Dhapte-Pawar, Arulmozhi Sathiyanarayanan, Apeksha Kanse · 2026 · International Journal of Pharmaceutics
- Cyclosporin (0.09%) Ophthalmic Solution for the Treatment of Dry Eye Disease – A Narrative ReviewSayan Basu, Elisabeth M. Messmer, Francisco C. Figueiredo, Gerd Geerling, Swati Singh, Anahita Kate, Zeenat Fatima, Amey Mane, Asif Shaikh, Suyog C. Mehta · 2026 · Current Eye Research
- Topical Cyclosporine in Ophthalmology: Current Formulations, Clinical Applications, Advantages, and Limitationsİlayda Korkmaz, Melis Palamar · 2026 · Journal of Ocular Pharmacology and Therapeutics